COMMUNIQUÉS West-GlobeNewswire

Doctors Manitoba selects Theresa Oswald as new CEO

17/11/2017 - 17:30

WINNIPEG, Manitoba, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Doctors Manitoba has selected Theresa Oswald as its new Chief Executive Officer starting in January 2018. Well known to the medical community around the country as [...]

American Health Council Recognizes Anikar Chhabra, MD, MS as “America’s Best Doctor”

17/11/2017 - 16:30

NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- The American Health Council names Anikar Chhabra as “America’s Best Doctor” for a dynamic medical career marked by compassionate patient care. Presently an Associate Professor [...]

MRI Interventions to Present at LD Micro Main Event Conference on December 6

17/11/2017 - 15:00

IRVINE, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), today announced that Joe Burnett, CEO, will present at the 10 th Annual LD Micro Main Event Conference on Wednesday, December 6, [...]

Flexion Therapeutics Named Top Place to Work for 2017 by The Boston Globe

17/11/2017 - 15:00

Annual survey recognizes and honors the best employers in Massachusetts BURLINGTON, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it has been named one of the [...]

VBL Therapeutics Prices 2.5 Million Ordinary Share Offering

17/11/2017 - 15:00

TEL AVIV, Israel, Nov. 17, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA

17/11/2017 - 14:43

NEWTOWN, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, has received [...]

ChemoCentryx to Participate at the Piper Jaffray 29th Annual Healthcare Conference

17/11/2017 - 14:30

MOUNTAIN VIEW, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]

Vilacto Bio Inc. Retains Established Independent Investor Relations Firm, The Equity Group Inc.

17/11/2017 - 14:30

COPENHAGEN, Denmark, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has retained The Equity Group Inc. to facilitate all aspects of the Company’s investor relations and [...]

International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

17/11/2017 - 14:30

CARLSBAD, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company [...]

Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma

17/11/2017 - 14:01

HAMPTON, N.J., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX ) announced today that enrollment has opened in its open-label Phase 2 study of CDX-3379 in combination with cetuximab in [...]

U.S. FDA Extends Review for TLANDO™; Advisory Committee Meeting Date of January 10, 2018 Remains Unchanged

17/11/2017 - 14:00

SALT LAKE CITY, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ: LPCN ), a specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (“FDA”) has extended the review period for the [...]

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

17/11/2017 - 13:39

$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu 177 Dotatate* (Lutathera ® ) for GEP-NETs Recent Highlights: Sales for the third quarter of 2017 increased 39% compared to the [...]

Optinose to Present at Piper Jaffray Healthcare Conference

17/11/2017 - 13:30

YARDLEY, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller [...]

Agios Presents Updated Phase 1 Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients with IDH1 Mutant Positive Glioma

17/11/2017 - 13:05

- Durable Stable Disease and Reduction of Tumor Growth Rates Observed for Patients with Low Grade Glioma; Median Treatment Duration of 16 Months with 51% of Patients Still on Treatment – - Ivosidenib Well-tolerated in [...]

ZIOPHARM Oncology to Host Conference Call on November 20, 2017 at 10:15 a.m. ET to Discuss Updated Clinical Data Presented at the 2017 Annual Meeting of the Society for Neuro-Oncology

17/11/2017 - 13:00

BOSTON, Nov. 17, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP ), a biopharmaceutical company developing new gene and cell-based immunotherapies for cancer, today announced that it will host a [...]

ReWalk Robotics Announces Pricing of Follow-on Public Offering of Ordinary Shares

17/11/2017 - 12:50

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK ) (“ ReWalk ” or the “ Company ”) today announced that it has priced its underwritten public offering of [...]

Digirad Corporation to Present at the 10th Annual LD Micro Main Event

17/11/2017 - 12:00

SUWANEE, Ga., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) announced today that it will be presenting at the 10 th annual LD Micro Main Event taking place December 5-7, 2017 at the Luxe Sunset [...]

Sentia Medical Sciences Inc. Announces the Launch of a New Initiative in Stress-related Disorders Targeting Gastrointestinal and Endocrine Diseases

17/11/2017 - 09:01

SAN DIEGO, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Sentia announced today that it will bring to fruition several decades of academic research by developing a new generation of first in class drug candidates called astressins [...]

NeuroSearch upgrades its guidance for 2017

17/11/2017 - 08:00

Company announcement 17 November 2017 NeuroSearch upgrades its guidance for 2017 from an operating loss of DKK 2.3-3.3 million, to an operation loss of approximately DKK 1 million. T he outlook does not include any [...]